Is ISRG stock a Buy, Sell, or Hold?

Based on our analysis, ISRG is currently a WAIT with low confidence. 📊 MIXED SIGNALS: ISRG shows conflicting indicators. Wait for confirmation before entering.

What is the fair value of ISRG stock?

Our analysis estimates the fair value range for ISRG to be between $392.01 and $430.52. The current price is $452.62.

What is the analyst price target for ISRG?

The average Wall Street analyst price target for ISRG is $480.17. This implies a potential upside of 8.2% from current levels.

Intuitive Surgical (ISRG) Stock: Buy, Sell, or Hold?

ISRG - Intuitive Surgical Inc.

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

$452.62

8.76 (1.97%) ▲

5d: +6.07%

30d: +13.29%

90d: +26.84%

WAIT

LOW Confidence

Protect Your ISRG Gains

Analysis Updated: Oct 23, 2026 12:00 AM ET

Earnings: Oct 20, 2026 0d

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Oct 21, 2026 at $428.12 · last confirmed Oct 23, 2026

Strength: 9.8/10

Get Alerted When ISRG Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 MIXED SIGNALS: ISRG shows conflicting indicators. Wait for confirmation before entering.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 10.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$433.88

Based on 7.0% avg growth

INTRINSIC VALUE TODAY

$269.41

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: ISRG is currently trading at $452.62, which is considered extended relative to its 30-day fair value range of $392.01 to $430.52. From a valuation perspective, the stock is trading at a discount (Forward PE: 35.8) compared to its historical average (40.2). Remarkably, the market is currently pricing in an annual earnings decline of 3.8% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, ISRG is in a strong downtrend. The price is approaching resistance at $458.45. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: ISRG scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $392.01 - $430.52

Company Quality Score 37/100 (SELL)

Volume Confirmation HIGH

Confidence Score 19.0%

Protect Your Profits

ISRG is technically overbought (RSI 72). Consider hedging now to protect against a potential pullback while keeping your upside.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range (+5.1% above its trading range)
BEARISH: Weak technical setup (15/100)
BULLISH: High volume confirmation
NEUTRAL: Near Wall St target ($480.17)
WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $392.01 - $430.52

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $398.99

Resistance Level $458.45

Current Trend Strong Downtrend

Technical data as of Oct 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) 35.83

Wall Street Target $480.17 (+8.2%)

Revenue Growth (YoY) 21.7%

Earnings Growth (YoY) -23.6%

Profit Margin 25.5%

Valuation Discount vs History -3.8% cheaper

PE vs Historical 35.8 vs 40.2 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -3.8% (market-implied from PE analysis)

1-Year Target $426.98 (-4%)

2-Year Target $410.76 (-8%)

3-Year Target $395.15 (-11%)

3-Yr Target (if PE normalizes) (PE: 36→40) $443.30 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 35.8, Growth: 10.0%) $590.87 (+33%)

Base: (SPY PE: 19.9, Growth: 10.0%) $327.47 (-26%)

Bear: (PE: 16.9, Growth: 10.0%) $278.35 (-37%)

📈 Valuation based on Current Earnings

Forward PE: 33.33 | Forward EPS (Implied): $13.32

Bull Case $535.95 (+21%)

Analyst growth 15.0%, PE expands to 35.0

Base Case $443.85 (0%)

Market implied 0.0%, PE stable at 33.3

Bear Case $339.55 (-24%)

Severe decline -15.0%, PE contracts to 30.0

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 35.8 to 40.2

Stabilization Target: $497.93 (+12.2%)

PE Expansion Potential: +12.2%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: October 23, 2026 2:44 PM ET
Data refreshes hourly during market hours. Next update: 3:44 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is ISRG showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for ISRG.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
ALC Alcon AG	STRONG BUY 27 analysts	$83	43 HOLD
RGEN Repligen Corporation	STRONG BUY 22 analysts	$198	57 HOLD
WST West Pharmaceutical Serv…	STRONG BUY 17 analysts	$413	37 SELL
STVN Stevanato Group SpA	BUY 14 analysts	$24	72 BUY
NVST Envista Holdings Corp	BUY 15 analysts	$29	72 BUY

ALC Alcon AG

43 HOLD

RGEN Repligen Corporat…

57 HOLD

WST West Pharmaceutic…

37 SELL

STVN Stevanato Group S…

72 BUY

NVST Envista Holdings …

72 BUY

Advanced ISRG Option Strategies

Professional options setups generated by AI based on today's ISRG price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ISRG

ISRG Technical Chart ISRG Price Prediction ISRG Earnings Date ISRG Investment Advisor ISRG Fair Price Analyzer ISRG Options Advisor ISRG Options Chain ISRG Options Analysis ISRG Competitors

Compare ISRG with Peers

ISRG vs VRTX
Which one to buy?

ISRG vs NOW
Which one to buy?

ISRG vs CRM
Which one to buy?

ISRG vs LRCX
Which one to buy?

ISRG vs MELI
Which one to buy?

ISRG vs TTWO

GFS vs ISRG

ISRG vs SPAI
Winner: ISRG

BKNG vs ISRG
Winner: BKNG

IRBT vs ISRG

Create New Comparison View All Competitors

Tradestie